Interferon-α Combined with Radiotherapy in the Treatment of Unresectable Melanoma

REFERENCES

• Measra B. W., Burton W. D. Primary Malignant Melanoma of the Upper Respiratory Tract. Cancer 1968; 21: 217–221
   PubMed Web of Science ®Google Scholar
• Baron P. L. The Surgical Management of Melanoma: From Diagnosis to Local Treatment. Semin. Oncol. 1996; 23: 714–718
   PubMed Web of Science ®Google Scholar
• Bentzen S. M., Overgaard J., Thames H. D., Overgaard M., Vejby P. Hansen, van der Maase H. Clinical Radiobiology of Malignant Melanoma. Radiother. Oncol. 1989; 16: 169–182
   PubMed Web of Science ®Google Scholar
• Konefal J. B. Analysis of Dose Fractionation in the Palliation of Metastases from Malignant Melanoma. Cancer 1988; 61: 243–246
   PubMed Web of Science ®Google Scholar
• Sause W. T., Cooper J. S., Rush S., Ago C. T., Cosmatos D., Coughlin C. T., Janjan N., Lipsett J. Fraction Size in External Radiation Therapy in the Treatment of Melanoma. Int. J. Radiat. Oncol. Biol. Phys. 1991; 20: 429–432
   PubMed Web of Science ®Google Scholar
• Harris J. R., Levine M. B. Visual Complications Following Irradiation for Pituitary Adenomas and Craniopharyngioma. Radiology 1976; 20: 167–171
   Google Scholar
• Lee S. P., Shimizu K. T., Tran L. M., Juillard J., Calcaterra T. C. Mucosal Melanoma of the Head and Neck: The Impact of Local Control on Survival. Laryngoscope 1994; 104: 121–126
   PubMed Web of Science ®Google Scholar
• Lund V. J. Malignant Melanoma of the Nasal Cavity and Paranasal Sinuses. Ear Nose Throat J. 1993; 72: 285–290
   PubMedGoogle Scholar
• Berthelsen A., Anderson A. P., Jensen T. S., Hansen H. S. Melanomas of the Mucosa in the Oral Cavity and the Upper Respiratory Passages. Cancer 1984; 54: 907–912
   PubMed Web of Science ®Google Scholar
• Houghton A. N., Meyers M. L., Chapman P. B. Medical Treatment of Metastatic Melanoma. Surg. Clin. North Am. 1996; 76: 1343–1354
   PubMed Web of Science ®Google Scholar
• Kirkwood J. M. Systemic Therapy of Melanoma. Curr. Opin. Oncol. 1994; 6: 204–211
   PubMedGoogle Scholar
• Agarwala S. S., Kirkwood J. M. Interferons in Melanoma. Curr. Opin. Oncol. 1996; 8: 167–174
   PubMedGoogle Scholar
• Legha S. S., Ring S., Eton O., Bedikian A., Buzaid A. C., Plager C., Papadopoulos N. Development of a Biochemotherapy Regimen with Concurrent Administration of Cisplatin, Vinblastin, Dacarbazine, Interferon Alpha, and Interleukin-2 for Patients with Metastatic Melanoma. J. Clin. Oncol. 1998; 16: 1752–1759
   PubMed Web of Science ®Google Scholar
• Khayat D., Borel C., Tourani J. M., Benhammouda A., Antoine E., Rixe O., Vuillemin E., Bazex P. A., Thill L., Franks R. Sequential Chemoimmunotherapy with Cisplatin, Interleukin-2, and Interferon Alpha-2a for Metastatic Melanoma. J. Clin. Oncol. 1993; 11: 2173–2180
   PubMed Web of Science ®Google Scholar
• Angioli R., Sevin B. U., Perras J. P., Untch M., Koechli O. R., Nguyen N. H., Steren A., Schwade J. G., Villani C., Averette H. E. In Vitro Potentiation of Radiation Cytotoxicity by Recombinant Interferons in Cervical Cancer Cell Lines. Cancer 1993; 71: 3717–3725
   PubMed Web of Science ®Google Scholar
• Chang A. Y., Keng P. C. Potentiation of Radiation Cytotoxicity by Recombinant Interferons, a Phenomenon Associated with Increased Blockage at the G2-M Phase of the Cell Cycle. Cancer Res. 1987; 47: 4338–4341
   PubMed Web of Science ®Google Scholar
• Kruninger L., Cottin E., Li Y. X., Noel A., Ozsahin M., Coucke P. A. Sensitizing Human Cervical Cancer Cells In Vitro to Ionizing Radiation with Interferon β or γ. Radiat. Res. 1999; 152: 493–498
   PubMed Web of Science ®Google Scholar
• Schmidberger H., Rave-Frank M., Lehman J., Schweinfurth S., Rehring E., Henckel K., Hess C. F. The Combined Effect of Interferon Beta and Radiation on Five Human Tumor Cell Lines and Embryonal Lung Fibroblasts. Int. J. Radiat. Oncol. Biol. Phys. 1999; 43: 405–412
   Google Scholar
• Sinclair W. K. Cyclic X-ray Responses in Mammalian Cells In Vitro. Radiat. Res. 1968; 33: 620–643
   PubMed Web of Science ®Google Scholar
• Creasley A. A., Bartholomew J. C., Merigan T. C. Role of G0–G1 Arrest in the Inhibition of Tumor Cell Growth by Interferon. Proc. Natl. Acad. Sci. 1980; 77: 1471–1475
   PubMed Web of Science ®Google Scholar
• Dritschilo A., Mossman K., Gray M., Sreevalsan T. Potentiation of Radiation Injury by Interferon. Am. J. Clin. Oncol. 1982; 5: 79–82
   PubMed Web of Science ®Google Scholar
• Syljuasen R. G., Belldegren A., Tso C. L., Withers H. R., McBride W. H. Sensitization of Renal Carcinoma to Radiation Using Alpha Interferon (IFNA) Gene Transfection Radiat. Res. 1997; 148: 443–448
   Google Scholar
• Ling C. C., Chen C. H., Li W. X. Apoptosis Induced at Different Dose Rates: Implication for the Shoulder Region of Cell Survival Curves. Radiat. Oncol. 1994; 32: 129–136
   Google Scholar
• Tamura T., Ueda S., Yoshida M., Matsuzaki M., Mohri H., Okubo T. Interferon-gamma Induces Ice Gene Expression and Enhances Cellular Susceptibility to Apoptosis in the U937. Biochem. Biophys. Res. Commun. 1996; 229: 21–26
   PubMed Web of Science ®Google Scholar
• Clave E., Carosella E. D., Gluckman E., Socie G. Radiation-Enhanced Expression of Interferon-Inducible Genes in the KG1a Primitive Hematopoietic Cell Line. Leukemia 1997; 11: 114–119
   PubMed Web of Science ®Google Scholar
• McDonald S., Chang A. Y., Rubin P., Wallenberg J., Kim I. S., Sobel S., Smith J., Keng P., Muhs A. Combined Betaseron and Radiation for Inoperable Non Small Cell Lung Cancer. Int. J. Radiat. Oncol. Biol. Phys. 1993; 27: 613–619
   PubMed Web of Science ®Google Scholar
• Rajkumar S. V., Buckner J. C., Schomberg P. J., Cascino T. L., Burch P. A., Dinapoli R. P. Phase I Evaluation of Radiation Combined with Recombinant Interferon Alpha-2a and BCNU for Patients with High-Grade Glioma. Int. J. Radiat. Oncol. Biol. Phys. 1998; 40: 297–302
   PubMed Web of Science ®Google Scholar